日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigation of the functional hot-spot residues of an enzyme by real-time monitoring of the enzymatic reaction using NMR and computational approaches

利用核磁共振和计算方法实时监测酶促反应,研究酶的功能热点残基

Sugiki, Toshihiko; Yoshida, Tomoki; Tsukamoto, Masaki; Miyanishi, Koichiro; Kagawa, Akinori; Miura, Natsuko; Ura, Tomoto; Fukazawa, Jun; Hatanaka, Yuko; Murata, Tsuyoshi; Fujiwara, Toshimichi; Kitagawa, Masahiro; Morita, Yasushi; Sakai-Kato, Kumiko; Takakusagi, Yoichi; Tanaka, Nobutada; Negoro, Makoto

Cerebral Sympathetic Nervous System Activation Promotes Intrarenal Renin-Angiotensin System Activity and Salt-Induced Nocturnal Polyuria.

脑交感神经系统激活促进肾内肾素-血管紧张素系统活性和盐诱导的夜间多尿。

Tsujimura Go, Takezawa Kentaro, Wakita Teppei, Kujime Yuma, Kitakaze Hiroaki, Ueda Norichika, Fukuhara Shinichiro, Kobuchi Shuhei, Fujisawa Yoshihide, Nishiyama Akira, Negoro Hiromitsu, Koyama Yoshihisa, Shimada Shoichi, Nonomura Norio

Expression of BMP-2, OPG, RANKL And Number of Osteoblasts After Application of Bovine Amniotic Membrane and Secretome Umbilical Cord in Wistar Rats

牛羊膜和分泌组脐带应用于Wistar大鼠后BMP-2、OPG、RANKL的表达及成骨细胞数量的变化

Setiawatie, Ernie Maduratna; Bargowo, Lambang; Supandi, Shafira Kurnia; Negoro, Vinanto Putero; Y P A, Ferlina Diah Ayu; K A, Elizabeth Luna; Agusta, Reinaldo; Baharuddin, Nor Adinar

Reply to 'The disruption of circadian rhythm as a potential mechanism of nocturia-like symptoms - a paediatric urology perspective'

回复“昼夜节律紊乱作为夜尿样症状的潜在机制——儿科泌尿学视角”

Song, Qi-Xiang; Suadicani, Sylvia; Negoro, Hiromitsu; Jiang, Hai-Hong; Jabr, Rita; Fry, Christopher; Xue, Wei; Damaser, Margot S

Disruption of circadian rhythm as a potential pathogenesis of nocturia

昼夜节律紊乱可能是夜尿症的潜在发病机制

Song, Qi-Xiang; Suadicani, Sylvia O; Negoro, Hiromitsu; Jiang, Hai-Hong; Jabr, Rita; Fry, Christopher; Xue, Wei; Damaser, Margot S

Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey

日本A20单倍体功能不全的临床特征和治疗策略:一项全国流行病学调查

Shiraki, Mayuka; Kadowaki, Saori; Miwa, Yuki; Nishimura, Kenichi; Maruyama, Yuta; Kishida, Dai; Imagawa, Kazuo; Kobayashi, Chie; Takada, Hidetoshi; Mitsunaga, Kanako; Inoue, Yuzaburo; Ebato, Takasuke; Miyamoto, Takayuki; Hiejima, Eitaro; Sato, Shuzo; Migita, Kiyoshi; Matsubayashi, Tadashi; Kobayashi, Daisuke; Hasegawa, Eriko; Kaneko, Utako; Ishikawa, Takashi; Onodera, Masafumi; Matsushita, Kohei; Koike, Yuhki; Umebayashi, Hiroaki; Kakuta, Fumihiko; Abukawa, Daiki; Funakoshi, Yasutomo; Ishimura, Masataka; Otani, Yusuke; Nishizawa, Takuya; Ishige, Takashi; Hatori, Reiko; Tanaka, Seiji; Kusunoki, Shouichirou; Nakamura, Kimitoshi; Shirai, Harumi; Hatai, Yoshiho; Miyaoka, Futaba; Kaneko, Shuya; Shimbo, Asami; Shimizu, Masaki; Kanegane, Hirokazu; Hashimoto, Motomu; Negoro, Nobuo; Yoshida, Taro; Wada, Yasunori; Usami, Masaaki; Wada, Taizo; Izawa, Kazushi; Yasumi, Takahiro; Nishikomori, Ryuta; Ohnishi, Hidenori

Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting

脂质体伊立替康+5-FU/LV与S-1治疗吉西他滨难治性转移性胰腺癌的疗效比较:一项采用逆概率加权法的真实世界研究

Imaoka, Hiroshi; Ikeda, Masafumi; Kobayashi, Satoshi; Ohba, Akihiro; Ueno, Masayuki; Suzuki, Yuko; Tsumura, Hidetaka; Kimura, Nana; Kawaguchi, Shinya; Kawamoto, Yasuyuki; Nakachi, Kohei; Tsuji, Kunihiro; Kobayashi, Noritoshi; Ashida, Reiko; Okano, Naohiro; Umemoto, Kumiko; Murohisa, Gou; Hosokawa, Ayumu; Asagi, Akinori; Nebiki, Hiroko; Suzuki, Rei; Terashima, Takeshi; Shibata, Ryusuke; Kawata, Kazuhito; Doi, Toshifumi; Ohyama, Hiroshi; Kitano, Yohei; Shioji, Kazuhiko; Okuyama, Hiroyuki; Naganuma, Atsushi; Negoro, Yuji; Sakamoto, Yasunari; Shimizu, Satoshi; Morizane, Chigusa; Ueno, Makoto; Furuse, Junji; Nagano, Hiroaki

Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting

更正:脂质体伊立替康+5-FU/LV与S-1治疗吉西他滨难治性转移性胰腺癌的疗效比较:一项采用逆概率加权法的真实世界研究

Imaoka, Hiroshi; Ikeda, Masafumi; Kobayashi, Satoshi; Ohba, Akihiro; Ueno, Masayuki; Suzuki, Yuko; Tsumura, Hidetaka; Kimura, Nana; Kawaguchi, Shinya; Kawamoto, Yasuyuki; Nakachi, Kohei; Tsuji, Kunihiro; Kobayashi, Noritoshi; Ashida, Reiko; Okano, Naohiro; Umemoto, Kumiko; Murohisa, Gou; Hosokawa, Ayumu; Asagi, Akinori; Nebiki, Hiroko; Suzuki, Rei; Terashima, Takeshi; Shibata, Ryusuke; Kawata, Kazuhito; Doi, Toshifumi; Ohyama, Hiroshi; Kitano, Yohei; Shioji, Kazuhiko; Okuyama, Hiroyuki; Naganuma, Atsushi; Negoro, Yuji; Sakamoto, Yasunari; Shimizu, Satoshi; Morizane, Chigusa; Ueno, Makoto; Furuse, Junji; Nagano, Hiroaki

Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B)

老年不可切除胆道癌患者的联合化疗:一项采用倾向评分匹配分析的前瞻性观察研究(JON2104-B)

Kobayashi, Satoshi; Nakachi, Kohei; Yamamoto, Kouji; Ueno, Makoto; Maruki, Yuta; Ikezawa, Kenji; Terashima, Takeshi; Shimizu, Satoshi; Oshima, Kotoe; Tsuji, Kunihiro; Masaki, Yoshiharu; Tsumura, Hidetaka; Shibuki, Taro; Ozaka, Masato; Okano, Naohiro; Okamura, Yukiyasu; Umemoto, Kumiko; Satoh, Tatsunori; Kojima, Yasushi; Shioji, Kazuhiko; Nebiki, Hiroko; Doi, Toshifumi; Naganuma, Atsushi; Kataoka, Shigeki; Kita, Emiri; Asama, Hiroyuki; Tsuchiya, Kaoru; Unno, Michiaki; Ashida, Reiko; Matsumoto, Kazuyuki; Ohno, Izumi; Itoi, Takao; Negoro, Yuji; Sakamoto, Yasunari; Arima, Shiho; Asagi, Akinori; Okuyama, Hiroyuki; Komatsu, Yoshito; Kobayashi, Noritoshi; Nagano, Hiroaki; Furuse, Junji

Synthesis of 5-Hydroxy-5-vinyl-2-cyclopentenones, a Family of Rare-Type Natural Products Mostly Recovered from Marine Sources

5-羟基-5-乙烯基-2-环戊烯酮的合成,这是一类主要从海洋来源中提取的稀有天然产物

Usami, Yoshihide; Asada, Natsuki; Shizuma, Chihiro; Negoro, Karin; Kawai, Ryosuke; Kaneda, Sayaka; Hayama, Noboru